These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Locked Nucleic Acid Gapmers and Conjugates Potently Silence ADAM33, an Asthma-Associated Metalloprotease with Nuclear-Localized mRNA. Pendergraff HM; Krishnamurthy PM; Debacker AJ; Moazami MP; Sharma VK; Niitsoo L; Yu Y; Tan YN; Haitchi HM; Watts JK Mol Ther Nucleic Acids; 2017 Sep; 8():158-168. PubMed ID: 28918018 [TBL] [Abstract][Full Text] [Related]
13. Towards Personalized Allele-Specific Antisense Oligonucleotide Therapies for Toxic Gain-of-Function Neurodegenerative Diseases. Helm J; Schöls L; Hauser S Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015334 [TBL] [Abstract][Full Text] [Related]
14. Development of gapmer antisense oligonucleotide with deoxyribonucleic guanidine (DNG) modifications. Kojima N; Shrestha AR; Akisawa T; Piao H; Kizawa H; Ohmiya Y; Kurita R Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):258-269. PubMed ID: 31556356 [TBL] [Abstract][Full Text] [Related]
15. Estimated number of off-target candidate sites for antisense oligonucleotides in human mRNA sequences. Yoshida T; Naito Y; Sasaki K; Uchida E; Sato Y; Naito M; Kawanishi T; Obika S; Inoue T Genes Cells; 2018 Jun; 23(6):448-455. PubMed ID: 29667281 [TBL] [Abstract][Full Text] [Related]
16. Lipid Conjugates Enhance Endosomal Release of Antisense Oligonucleotides Into Cells. Wang S; Allen N; Prakash TP; Liang XH; Crooke ST Nucleic Acid Ther; 2019 Oct; 29(5):245-255. PubMed ID: 31158063 [TBL] [Abstract][Full Text] [Related]
17. Factors Influencing ADME Properties of Therapeutic Antisense Oligonucleotides: Physicochemical Characteristics and Beyond. Jiang R; Hooshfar S; Rebecca Eno M; Yun C; Sonego Zimmermann E; Shinkyo R Curr Drug Metab; 2023; 24(7):536-552. PubMed ID: 37076460 [TBL] [Abstract][Full Text] [Related]
18. Probing the influence of stereoelectronic effects on the biophysical properties of oligonucleotides: comprehensive analysis of the RNA affinity, nuclease resistance, and crystal structure of ten 2'-O-ribonucleic acid modifications. Egli M; Minasov G; Tereshko V; Pallan PS; Teplova M; Inamati GB; Lesnik EA; Owens SR; Ross BS; Prakash TP; Manoharan M Biochemistry; 2005 Jun; 44(25):9045-57. PubMed ID: 15966728 [TBL] [Abstract][Full Text] [Related]
19. Albumin-Binding Fatty Acid-Modified Gapmer Antisense Oligonucleotides for Modulation of Pharmacokinetics. Cai Y; Lou C; Wengel J; Howard KA Methods Mol Biol; 2020; 2176():163-174. PubMed ID: 32865790 [TBL] [Abstract][Full Text] [Related]